5426652025-07-012025-09-305426652025-09-305426652025-03-315426652025-04-012025-09-305426652025-07-012025-09-30in-capmkt:OtherExpenses1Member5426652025-04-012025-09-30in-capmkt:OtherExpenses1Member5426652025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15426652025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15426652025-07-012025-09-30RelatedPartyTransactionDomain15426652025-06-30RelatedPartyTransactionDomain15426652025-09-30RelatedPartyTransactionDomain15426652025-07-012025-09-30RelatedPartyTransactionDomain25426652025-06-30RelatedPartyTransactionDomain25426652025-09-30RelatedPartyTransactionDomain25426652025-07-012025-09-30RelatedPartyTransactionDomain35426652025-06-30RelatedPartyTransactionDomain35426652025-09-30RelatedPartyTransactionDomain35426652025-07-012025-09-30RelatedPartyTransactionDomain45426652025-06-30RelatedPartyTransactionDomain45426652025-09-30RelatedPartyTransactionDomain45426652025-07-012025-09-30RelatedPartyTransactionDomain55426652025-06-30RelatedPartyTransactionDomain55426652025-09-30RelatedPartyTransactionDomain55426652025-07-012025-09-30RelatedPartyTransactionDomain65426652025-06-30RelatedPartyTransactionDomain65426652025-09-30RelatedPartyTransactionDomain65426652025-07-012025-09-30RelatedPartyTransactionDomain75426652025-06-30RelatedPartyTransactionDomain75426652025-09-30RelatedPartyTransactionDomain75426652025-07-012025-09-30RelatedPartyTransactionDomain85426652025-06-30RelatedPartyTransactionDomain85426652025-09-30RelatedPartyTransactionDomain85426652025-07-012025-09-30RelatedPartyTransactionDomain95426652025-06-30RelatedPartyTransactionDomain95426652025-09-30RelatedPartyTransactionDomain95426652025-07-012025-09-30RelatedPartyTransactionDomain105426652025-06-30RelatedPartyTransactionDomain105426652025-09-30RelatedPartyTransactionDomain105426652025-07-012025-09-30RelatedPartyTransactionDomain115426652025-06-30RelatedPartyTransactionDomain115426652025-09-30RelatedPartyTransactionDomain115426652025-07-012025-09-30RelatedPartyTransactionDomain125426652025-06-30RelatedPartyTransactionDomain125426652025-09-30RelatedPartyTransactionDomain125426652025-07-012025-09-30RelatedPartyTransactionDomain135426652025-06-30RelatedPartyTransactionDomain135426652025-09-30RelatedPartyTransactionDomain135426652025-07-012025-09-30RelatedPartyTransactionDomain145426652025-06-30RelatedPartyTransactionDomain145426652025-09-30RelatedPartyTransactionDomain145426652025-07-012025-09-30RelatedPartyTransactionDomain155426652025-06-30RelatedPartyTransactionDomain155426652025-09-30RelatedPartyTransactionDomain155426652025-07-012025-09-30RelatedPartyTransactionDomain165426652025-06-30RelatedPartyTransactionDomain165426652025-09-30RelatedPartyTransactionDomain165426652025-07-012025-09-30RelatedPartyTransactionDomain175426652025-06-30RelatedPartyTransactionDomain175426652025-09-30RelatedPartyTransactionDomain175426652025-07-012025-09-30RelatedPartyTransactionDomain185426652025-06-30RelatedPartyTransactionDomain185426652025-09-30RelatedPartyTransactionDomain185426652025-07-012025-09-30RelatedPartyTransactionDomain195426652025-06-30RelatedPartyTransactionDomain195426652025-09-30RelatedPartyTransactionDomain195426652025-07-012025-09-30RelatedPartyTransactionDomain205426652025-06-30RelatedPartyTransactionDomain205426652025-09-30RelatedPartyTransactionDomain205426652025-07-012025-09-30RelatedPartyTransactionDomain215426652025-06-30RelatedPartyTransactionDomain215426652025-09-30RelatedPartyTransactionDomain215426652025-07-012025-09-30RelatedPartyTransactionDomain225426652025-06-30RelatedPartyTransactionDomain225426652025-09-30RelatedPartyTransactionDomain225426652025-07-012025-09-30RelatedPartyTransactionDomain235426652025-06-30RelatedPartyTransactionDomain235426652025-09-30RelatedPartyTransactionDomain235426652025-07-012025-09-30RelatedPartyTransactionDomain245426652025-06-30RelatedPartyTransactionDomain245426652025-09-30RelatedPartyTransactionDomain245426652025-07-012025-09-30RelatedPartyTransactionDomain255426652025-06-30RelatedPartyTransactionDomain255426652025-09-30RelatedPartyTransactionDomain255426652025-07-012025-09-30RelatedPartyTransactionDomain265426652025-06-30RelatedPartyTransactionDomain265426652025-09-30RelatedPartyTransactionDomain265426652025-07-012025-09-30RelatedPartyTransactionDomain275426652025-06-30RelatedPartyTransactionDomain275426652025-09-30RelatedPartyTransactionDomain275426652025-07-012025-09-30RelatedPartyTransactionDomain285426652025-06-30RelatedPartyTransactionDomain285426652025-09-30RelatedPartyTransactionDomain285426652025-07-012025-09-30RelatedPartyTransactionDomain295426652025-06-30RelatedPartyTransactionDomain295426652025-09-30RelatedPartyTransactionDomain295426652025-07-012025-09-30RelatedPartyTransactionDomain305426652025-06-30RelatedPartyTransactionDomain305426652025-09-30RelatedPartyTransactionDomain305426652025-07-012025-09-30RelatedPartyTransactionDomain315426652025-06-30RelatedPartyTransactionDomain315426652025-09-30RelatedPartyTransactionDomain315426652025-07-012025-09-30RelatedPartyTransactionDomain325426652025-06-30RelatedPartyTransactionDomain325426652025-09-30RelatedPartyTransactionDomain325426652025-07-012025-09-30RelatedPartyTransactionDomain335426652025-06-30RelatedPartyTransactionDomain335426652025-09-30RelatedPartyTransactionDomain335426652025-07-012025-09-30AuditorDomain15426652025-09-30Statement15426652025-07-012025-09-30Statement1iso4217:INRxbrli:pureiso4217:INRxbrli:shares542665NEOGENNOTLISTEDINE136S01016Neogen Chemicals LimitedMain BoardEquity2025-04-012026-03-312025-11-082025-11-05INRCroresQuarterlySecond quarterSingle segmentSpecialty Chemicals2025-11-0814:30:002025-11-0818:15:00trueCash Flow IndirectDeclaration of unmodified opiniontruetrueNANAfalsetrue2024-04-30https://neogenchem.com/wp-content/uploads/Policy-on-Materiality-of-Related-Party-Transactions-and-Dealing-with-Related-Party-Transactions-1.pdftrue1falseNot applicable.2025-07-012025-09-30UnauditedStandalone206680000043700000211050000015449000000-427100000201200000206000000639000003983000001987200000123300000012330000037700000-750000030200000093100000000093100000-90000092200000263800000103.533.53003.533.531. Additional disclosures pursuant to regulation 52(4) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. For detailed notes visit https://neogenchem.com/wp-content/uploads/ocm-bm-002.pdf <BR> 2.The above unaudited financial results of the Company for the quarter and half year ended September 30, 2025 have been prepared in accordance with the IND AS, as prescribed under section 133 of the Companies Act, 2013 read with the Companies (Indian Accounting Standards) Rules, 2015 as amended and the other accounting principles generally accepted in India and are in compliance with the disclosure requirement of Regulations 33 and Regulations 52 of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015 as amended and were reviewed by the Statutory Auditor and recommended by the Audit Committee in its meeting held on November 08, 2025, to the Board for approval and was approved by the Board of Directors at their meeting held on November 08, 2025. <BR> For detailed Notes to financial statement please visit https://neogenchem.com/wp-content/uploads/ocm-bm-002.pdf <BR> 2025-04-012025-09-30UnauditedStandalone391260000076800000398940000028189000000-6882000003735000003463000001127000007121000003675300000314100000031410000086200000-76000007860000002355000000000235500000-1800000233700000263800000108.938.93008.938.93Other Expenses398300000Other Expenses712100000198280000054320000000522400000000299740000008395000003218000004158700000014440000073515000004275400000100450000027119000001020000003000000344520000071748000000686300000121365000000019488000000263800000802810000082919000008291900000239120000000044310000028343000001126000002059000000031528000004827800000123600000256230000026859000003823000007896000000818000003950000026000000080433000000011196100000194880000001. Additional disclosures pursuant to regulation 52(4) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. For detailed notes visit https://neogenchem.com/wp-content/uploads/ocm-bm-002.pdf <BR> 2.The above unaudited financial results of the Company for the quarter and half year ended September 30, 2025 have been prepared in accordance with the IND AS, as prescribed under section 133 of the Companies Act, 2013 read with the Companies (Indian Accounting Standards) Rules, 2015 as amended and the other accounting principles generally accepted in India and are in compliance with the disclosure requirement of Regulations 33 and Regulations 52 of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015 as amended and were reviewed by the Statutory Auditor and recommended by the Audit Committee in its meeting held on November 08, 2025, to the Board for approval and was approved by the Board of Directors at their meeting held on November 08, 2025. <BR> For detailed Notes to financial statement please visit https://neogenchem.com/wp-content/uploads/ocm-bm-002.pdf <BR> 346300000-1213300000-7572000000-417400000-1353000005120000020880000001345000000-2022000007700000112700000000765000002000000230000006590000069000000003340000000-1809000000-1494900000000600000000-1554900000825000001066300000000000861000000339000000-222600000000000000000000006020000008091000001849000000000000031076000003321000005500000003326000000-7900000238000000010100000000101000000048000001014800000Items that will not be reclassified to profit or loss-1200000-1200000Items that will not be reclassified to profit or loss-2400000-2400000-300000-60000000-900000-1800000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiaryInterest receivedApproved51500000100000039100000Neogen Chemicals Limited******Dhara Fine Chem Industries******Joint VentureInterest received100000000Approved50000000Neogen Chemicals Limited******Neogen Chemicals Japan Corporation Limited******Wholly Owned SubsidiaryInvestmentApproved11900000011900000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiaryInter-corporate depositApproved-82500000918500000836000000ICD Given (Rs. 37.17 Crore) and ICD received back (Rs. 45.42). Net Amount (Rs. 83.60)Neogen Chemicals Limited******Kagashin Global network private limited******A private Company wherein a Director of the Company is acting as a DirectorPurchase of goods or servicesApproved110000002300000-6400000Neogen Chemicals Limited******Dhara Fine Chem Industries******Joint VenturePurchase of goods or services100000000Approved29900000-12300000-14900000Purchase of servicesNeogen Chemicals Limited******Dhara Fine Chem Industries******Joint VenturePurchase of goods or services100000000Approved200000000Purchase of GoodsNeogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiaryPurchase of goods or servicesApproved9900000-6200000-16200000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiarySale of goods or servicesApproved5730000037970000033600000Neogen Chemicals Limited******Dhara Fine Chem Industries******Joint VentureSale of goods or services100000000Approved9000001180000014600000Neogen Chemicals Limited******Kagashin Global network private limited******A private Company wherein a Director of the Company is acting as a DirectorAny other transactionReimbursement of expenses (expense)Approved240000000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiaryAny other transactionReimbursement of expenses (income)Approved152800000100610000073800000Neogen Chemicals Limited******Avi Sabavala******Independent DirectorAny other transactionSitting feesApproved30000000Neogen Chemicals Limited******Prof. Ranjan Malik******Independent DirectorAny other transactionSitting feesApproved30000000Neogen Chemicals Limited******Manojkumar Pati******Independent DirectorAny other transactionSitting feesApproved30000000Neogen Chemicals Limited******Rajeshkumar Shah******Independent DirectorAny other transactionSitting feesApproved20000000Neogen Chemicals Limited******Dhara Fine Chem Industries******Joint VentureAny other transactionShare of profit100000000Approved1400000015800000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiaryInvestmentApproved105000000018250000002875000000Subscription of 10,50,00,000 CCDs of Rs. 10 each issued by Neogen Ionics Limited (the Wholly Owned Subsidiary)Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiaryAny other transactionRent IncomeApproved30000000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiarySale of fixed assetsApproved30000000Neogen Chemicals Limited******Unnati Kanani******Company Secretary and Compliance OfficerRemunerationApproved190000000Neogen Chemicals Limited******Gopikrishnan Sarathy******CFORemunerationApproved770000000Neogen Chemicals Limited******Shyamsunder Upadhyay******Whole time DirectorRemunerationApproved620000000Neogen Chemicals Limited******Dr. Harin Kanani******Managing DirectorRemunerationApproved690000000Neogen Chemicals Limited******Haridas Kanani******Chairman and Managing DirectorRemunerationApproved690000000Neogen Ionics Limited******Sanjay Mehta******Independent DirectorAny other transactionSitting feesApproved10000000Neogen Ionics Limited******Prof. Ranjan Malik******Independent DirectorAny other transactionSitting feesApproved10000000Neogen Ionics Limited******Hitesh Reshamwala******Independent DirectorAny other transactionSitting feesApproved10000000Neogen Ionics Limited******Neogen Morita New Materials Limited******Wholly Owned SubsidiaryInvestmentApproved100000001000000Subscription of 1,00,000 equity shares of Rs. 10 each issued by Neogen Morita New Materials Limited (the Wholly Owned Subsidiary), pursuant to its incorporation.Neogen Ionics Limited******Neogen Morita New Materials Limited******Wholly Owned SubsidiaryAny other transactionRent IncomeApproved100000001000000Neogen Morita New Materials Limited******Neogen Chemicals Limited******Step Down SubsidiaryAny other transactionReimbursement of expenses (expense)Approved6000000-600000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiaryAny other transactionCorporate Guarantee feesApproved400000000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiaryAny other transactionShare based paymentApproved60000000As per IND AS, The same has been considered as an investment in Neogen Ionics Limited1337800000UnauditedtrueM/s. Chandabhoy & Jassoobhoy, Chartered Accountantstrue2026-10-31OthersIssue of 20,000 fully paid, secured, listed, rated, redeemable, rupee denominated, non-cumulative, non-convertible debentures having a face value of INR 1,00,000 each (“NCDs”) aggregating to Rs. 2,00,00,00,000 (Rupees Two hundred crores only) on private placement basis.2025-08-1220000000002025-09-30falsefalseN.A.N.A.N.A.Gopikrishnan SarathyChief Financial OfficerThane2025-11-08